Effect of levamisole on Mycobacterium leprae in mice.
AUTOR(ES)
Shepard, C C
RESUMO
Levamisole, an antihelminthic drug that is capable of enhancing immune responses in mice and in humans, was tested in experimental Mycobacterium leprae infections in mice by a number of schedules. Intermittent schedules were used, and administration of the drug was started (i) around the time of inoculation with M. leprae, (ii) when the M. leprae population was approaching the plateau level, (iii) after the onset of the plateau phase, or (iv) after BCG vaccination 28 days following the inoculation with M. leprae. No effect of drug could be discerned with any of the schedules.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=420993Documentos Relacionados
- Effect of thymectomy and antilymphocyte serum on Mycobacterium leprae infection in mice.
- Effect of low-level and intermittent minocycline therapy on the growth of Mycobacterium leprae in mice.
- Viability of Mycobacterium leprae after multiplication in mice.
- Effects of Propionibacterium acnes treatment on the course of Mycobacterium leprae infection in mice.
- Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.